Results 151 to 160 of about 284,529 (384)

Neoplasia of aortic intima [PDF]

, 1964
R. A. Sladden
openalex   +1 more source

Swab‐based anal cancer screening in men living with HIV: Projected outcomes for different screening algorithms

International Journal of Cancer, EarlyView.
What's New? Screening, combined with treatment of precancerous lesions, is key to preventing anal cancer. Here, the authors compare different screening algorithms. The International Anal Neoplasia Society recommends swab‐based screening as a first step, either cytology‐based or HPV‐based, and digital anal rectal exam (DARE).
Kirsten Rozemeijer, Fernando Dias Gonçalves Lima, Esther J. Kuyvenhoven, Henry J. C. de Vries, Renske D. M. Steenbergen, Jan M. Prins, Matthijs L. Siegenbeek van Heukelom   +6 more
wiley   +1 more source

MALIGNANT NEOPLASIA IN THE GALL-BLADDER

, 1921
James A.H. Magoun, Kinsley Renshaw
openalex   +2 more sources

An unusual presentation of pheochromocytoma accompanied by catecholamine‐induced cardiomyopathy

ESC Heart Failure, EarlyView.
Hugh O.J. Roberts, Alexandru Munteanu, Jonas E. Mertens   +2 more
wiley   +1 more source

ADAR1 mRNA quantification for predicting HSIL in persons with HIV and abnormal anal cytology

International Journal of Cancer, EarlyView.
What's New? This study introduces ADAR1 mRNA quantification as a promising biomarker for improving high‐grade squamous intraepithelial lesion (HSIL) prediction in HIV‐positive individuals with abnormal anal cytology. With 92% specificity, it reduces unnecessary high‐resolution anoscopies (HRA) by 77%, offering a more efficient and targeted screening ...
Melissa Bello‐Perez, Paula Mascarell, Marta Fernández‐González, Jose Alberto García, Ana Gutiérrez‐Ortiz de la Tabla, Christian Ledesma, Alba De la Rica, Antonio Galiana, Leo López, Maria Dolores Ocete, Carme Salvador, Concepción Gimeno, Javier García‐Abellán, Sergio Padilla, Félix Gutiérrez, Mar Masiá   +15 more
wiley   +1 more source

La experiencia de sufrimiento en cuidadores principales de pacientes con dolor oncológico y no oncológico

Avances en Enfermería, 2010
El objetivo de la investigación es describir la experiencia de sufrimiento de los cuidadores informales de pacientes con dolor oncológico y no oncológico de tres instituciones de salud de Medellín. Es una investigación cualitativa de tipo fenomenológico.
ALICIA KRIKORIAN D, MARÍA CLARA VÉLEZ A, OLGA GONZÁLEZ T, CAROLINA PALACIO G, JOHN JAIRO VARGAS G   +4 more
doaj  

Neoplasia and Internal Environment

, 1955
F Bielschowsky
openalex   +1 more source

Hormones and neoplasia [PDF]

Journal of Clinical Pathology, 1974
openaire   +4 more sources

Design and initial findings of a natural history study of anal HPV and associated lesions among young adult women in Costa Rica

International Journal of Cancer, EarlyView.
What's New? Infection with human papillomavirus (HPV) is the primary cause of anal cancer, for which the majority of cases occur in women. Anal cancer screening guidelines have limited evidence to inform effective strategies for women with HIV. We designed a study that was nested within the Costa Rica HPV Vaccine Trial to understand the natural history
Cameron B. Haas, Rebeca Ocampo, Danping Liu, Michael Zúñiga, Diego Guillen, Megan A. Clarke, Loretto J. Carvajal, Allan Hildesheim, John Schussler, Mónica Sierra, Teresa M. Darragh, Joel M. Palefsky, Carolina Porras, for the Costa Rica HPV Vaccine Trial (CVT) Group, Bernal Cortés, Paula González, Rolando Herrero, Silvia E. Jiménez, Carolina Porras, Ana Cecilia Rodríguez, Allan Hildesheim, Aimée R. Kreimer, Douglas R. Lowy, Mark Schiffman, John T. Schiller, Mark Sherman, Ligia A. Pinto, Troy J. Kemp, Leidos Biomedical Research, Frederick National Laboratory, Cancer Research, Mary K. Sidawy, Wim Quint, Joel M. Palefsky, Mark H. Stoler, Aimée R. Kreimer, Rolando Herrero   +36 more
wiley   +1 more source

Ahorros para el sistema de salud colombiano con la financiación externa de estudios clínicos oncológicos

Biomédica: revista del Instituto Nacional de Salud
Introducción. El gasto en medicamentos para tratar el cáncer aumentará entre el 9 y el 12 % anual hasta el 2025. Para los sistemas de salud de los países con un ingreso medio-alto, como Colombia, y con una tendencia creciente de nuevos casos de cáncer ...
Sandra Aruachan Vesga, Manuel González, Danis M. Rojas, Javier Ospina, Santiago Duque-Varela, Andrés Ángel Castaño   +5 more
doaj   +1 more source